BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12088276)

  • 1. Lipid mediators in epithelial cell-cell interactions.
    Colgan SP
    Cell Mol Life Sci; 2002 May; 59(5):754-60. PubMed ID: 12088276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated endothelial cells elicit paracrine induction of epithelial chloride secretion. 6-Keto-PGF1alpha is an epithelial secretagogue.
    Blume ED; Taylor CT; Lennon PF; Stahl GL; Colgan SP
    J Clin Invest; 1998 Sep; 102(6):1161-72. PubMed ID: 9739050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways.
    Serhan CN; Oliw E
    J Clin Invest; 2001 Jun; 107(12):1481-9. PubMed ID: 11413151
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid inflammatory mediators in diabetic vascular disease.
    Natarajan R; Nadler JL
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1542-8. PubMed ID: 15166011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PGG2, 11R-HPETE and 15R/S-HPETE are formed from different conformers of arachidonic acid in the prostaglandin endoperoxide H synthase-1 cyclooxygenase site.
    Thuresson ED; Lakkides KM; Smith WL
    Adv Exp Med Biol; 2002; 507():67-72. PubMed ID: 12664566
    [No Abstract]   [Full Text] [Related]  

  • 6. Crosstalk of oncogenic and prostanoid signaling pathways.
    Müller R
    J Cancer Res Clin Oncol; 2004 Aug; 130(8):429-44. PubMed ID: 15205946
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of leukocyte transmigration: cell surface interactions and signaling events.
    Liu Y; Shaw SK; Ma S; Yang L; Luscinskas FW; Parkos CA
    J Immunol; 2004 Jan; 172(1):7-13. PubMed ID: 14688302
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.
    Serhan CN; Clish CB; Brannon J; Colgan SP; Chiang N; Gronert K
    J Exp Med; 2000 Oct; 192(8):1197-204. PubMed ID: 11034610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E synthase: another enzyme in the cyclooxygenase pathway driving epithelial cancer?
    Kurie JM; Dubois RN
    Clin Cancer Res; 2001 Sep; 7(9):2608-10. PubMed ID: 11555570
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid mediator networks and leukocyte transmigration.
    Louis NA; Hamilton KE; Colgan SP
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):197-202. PubMed ID: 15979294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclooxygenase-1/cyclooxygenase-2 inhibition on leukocyte/endothelial cell interactions in the rat mesentery.
    Calatayud S; Mitchell JA; Perretti M; Giuliano F; Warner TD
    Eur J Pharmacol; 2002 Apr; 440(1):71-7. PubMed ID: 11959090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression.
    Goulet AC; Einsphar JG; Alberts DS; Beas A; Burk C; Bhattacharyya A; Bangert J; Harmon JM; Fujiwara H; Koki A; Nelson MA
    Cancer Biol Ther; 2003; 2(6):713-8. PubMed ID: 14688483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis.
    Tsai CH; Chou MY; Chang YC
    J Oral Pathol Med; 2003 Mar; 32(3):146-53. PubMed ID: 12581384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation.
    Jones RL; Kelly RW; Critchley HO
    Hum Reprod; 1997 Jun; 12(6):1300-6. PubMed ID: 9222021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease.
    Pouliot M; Clish CB; Petasis NA; Van Dyke TE; Serhan CN
    Biochemistry; 2000 Apr; 39(16):4761-8. PubMed ID: 10769133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release.
    Gronert K; Gewirtz A; Madara JL; Serhan CN
    J Exp Med; 1998 Apr; 187(8):1285-94. PubMed ID: 9547339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection with high-density lipoproteins: fact or fiction?
    Das DK
    Circ Res; 2003 Feb; 92(3):258-60. PubMed ID: 12595335
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclooxygenase 2-derived prostaglandin E2 production by corticotropin-releasing hormone contributes to the activated cAMP response element binding protein content in rheumatoid arthritis synovial tissue.
    McEvoy AN; Bresnihan B; FitzGerald O; Murphy EP
    Arthritis Rheum; 2004 Apr; 50(4):1132-45. PubMed ID: 15077295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions.
    Serhan CN; Clish CB; Brannon J; Colgan SP; Gronert K; Chiang N
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):643-54. PubMed ID: 11192938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.